Accelerating
Bio-Innovation Conference
Translating research into medicines, and bringing thought leaders together to generate new ideas and partnerships.
Royalty Pharma Translational Prize
The Royalty Pharma Translational Prize honors scientific breakthroughs that bridge the gap between fundamental discovery and the development of new medicines that improve and extend patients’ lives. It is awarded annually to one or more established scientists whose work has translated unique scientific insights into medicines with significant impact, particularly contributions not yet recognized by the field’s most prominent awards.
A forum for innovation
An invitation-only event for global innovators in life sciences
Our 2026 summit was held in partnership with the University of Cambridge and connected hundreds of diverse participants, including executives, scientists and Nobel laureates.
View ABI website
Accelerating Bio-Innovation Conference 2027
The next conference will be the most memorable yet
Returning to Massachusetts Institute of Technology after ABI26 at the University of Cambridge, ABI27 will bring together more thought leaders from the bio-innovation sphere than ever before. Topics will range from the challenges of finding new innovative drugs, to collaborations between academia, industry and finance.
I’ve been to all Accelerating Bio-Innovation conferences and there’s incredible diversity. It’s wide ranging and the one place where you see the entire gamut of technologies, right from the laboratory, all the way to becoming a clinical reality in patients. It is the one place where you meet all the stakeholders that have played a role along the way, the scientists and the inventors, the technologists, the clinical trialists, the physicians, the regulatory folks and the entrepreneurs who make all of this a reality.
Siddhartha Mukherjee MD, PhD
Pulitzer Prize awardee
Latest discussions on translational sciences and drug development
Hear from thought leaders across the biopharma space
ABI26 video gallery
